Cargando…
Tacrolimus Use and COVID-19 Infection in Patients After Solid Organ Transplantation
Autores principales: | Yin, Saifu, Wang, Xianding, Song, Turun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the AGA Institute
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848533/ https://www.ncbi.nlm.nih.gov/pubmed/33539863 http://dx.doi.org/10.1053/j.gastro.2021.01.223 |
Ejemplares similares
-
Increasing Time in Therapeutic Range of Tacrolimus in the First Year Predicts Better Outcomes in Living-Donor Kidney Transplantation
por: Song, Turun, et al.
Publicado: (2019) -
Ameliorating Metabolic Profiles After Kidney Transplantation: A Protocol for an Open-Label, Prospective, Randomized, 3-Arm, Controlled Trial
por: Yin, Saifu, et al.
Publicado: (2021) -
Tacrolimus Trough Level at the First Month May Predict Renal Transplantation Outcomes Among Living Chinese Kidney Transplant Patients: A Propensity Score–Matched Analysis
por: Yin, Saifu, et al.
Publicado: (2019) -
Transplant outcomes of 100 cases of living-donor ABO-incompatible kidney transplantation
por: Yin, Saifu, et al.
Publicado: (2022) -
Incidence, risk factors, and clinical outcomes of HBV reactivation in non-liver solid organ transplant recipients with resolved HBV infection: A systematic review and meta-analysis
por: Yin, Saifu, et al.
Publicado: (2023)